F.T.C. Accuses Drug Middlemen of Inflating Insulin PricesSep 20, 2024The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.Read the full story >
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.Read the full story >
ความคิดเห็น